SYLOID® mesoporous silicas and VYVID™ superparamagnetic silicas

SYLOID® mesoporous silicas and VYVID™ superparamagnetic silicas
Product Description

SYLOID® FP mesoporous silica is the ideal choice for formulations due to its unique morphology to help improve the handling, adsorption, and dissolution of many pharmaceuticals. - Effective desiccant to increase the stability of moisture-sensitive APIs - Efficient conditioner for powder formulations used in suspensions - Capillary wetting agent for better release and disintegration - Contribution to the controlled release of active pharmaceutical ingredients (API) - Low dusting and easy to handle SYLOID® XDP silica is an optimized mesoporous material engineered for transforming liquids to free-flowing solids, particularly oily actives, and lipid-based systems. - Solid carrier for lipid-based drug delivery systems - Transform liquids to easy-to-handle solids - Improve bioavailability of oily actives - Increase API loading in solid dosage forms - Release API's quickly and completely from solid dosage forms - Create liquisolid formulations VYVID™ magnetic particles are suitable for applications involving high-throughput nucleic acid extraction and screening assays, manual small-scale isolation, or cell separation applications. VYVID™ features our novel particle design that clads a superparamagnetic core with silica to eliminate the need for chromatography, centrifugation or vacuum filtration steps required in typical biomolecule purifications. The beads’ superb magnetic response enables speed and efficiency in separation. Plus, the beads lose all their magnetization once the external magnetic field is removed, so they can be resuspended immediately, dispersing easily with no residual bead-to-bead magnetic attraction. Available in various particle sizes, surface modifications and silica to magnetite compositions, from small to multi-ton quantities to meet your requirements.

Grace GmbH

  • DE
  • 2022
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

Grace GmbH

  • DE
  • 2022
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Grace GmbH (5)

  • Custom Fine Chemical Manufacturing

    Product Custom Fine Chemical Manufacturing

    Our comprehensive portfolio of services, integrated manufacturing, and regulatory leadership differentiates us as a leading contract development and manufacturing partner. With a proven ability to deliver solutions to complex challenges, Grace’s FCMS supports the entire small molecule development cycle fro...
  • Generic APIs

    Product Generic APIs

    Grace's Fine Chemical Manufacturing Services (FCMS) has a long history of supplying high-quality generic and custom APIs to the pharmaceutical and nutraceutical markets. Grace's FCMS has manufactured some of the most notable APIs that are now part of our portfolio of generic products available to devel...
  • Multifunctional Excipients for the Nutraceutical and Pharmaceutical Industry

    Product Multifunctional Excipients for the Nutraceutical and Pharmaceutical Industry

    Our SYLOID® FP silica excipients are a strategic drug development tools in today’s challenging pharmaceutical industry with its demands for improved formulations, bringing new drugs to market faster, and technological advances.

    SYLOID® FP silica’s unique, innovative design combine...
  • Custom Bonding and Chromatography Resins for Small and Large Molecule Purification

    Product Custom Bonding and Chromatography Resins for Small and Large Molecule Purification

    Grace offers high quality chromatography silica resins with a wide range of pore diameters, particle sizes, and chromatography phases. We provide custom bonding of silica (30Å-4500Å; 5µm to 200µm) for different reversed and normal phases, ion exchange, and other chemistries. We develop and manufacture ...
  • Drug Delivery for Enhanced Bioavailability of BCS2 (Poorly Soluble) Compounds

    Product Drug Delivery for Enhanced Bioavailability of BCS2 (Poorly Soluble) Compounds

    Engineered to bring together advanced silica technologies with challenging active pharmaceutical ingredients (APIs) to effectively formulate a large class of poorly soluble but otherwise promising compounds, Grace’s SILSOL® silica-based drug delivery technology provides solutions for poorly soluble active ...

Grace GmbH resources (1)

  • Brochure Pharmaceutical Solutions

    W. R. Grace & Co.’s history of exceeding customer expectations is built upon our unyielding commitment to innovation and advancement of technical expertise, which is reflected throughout the drug development process.

    Grace’s Portfolio for Pharmaceutical Solutions Includes:


    Fine chemicals synthesis expertise
    Decades of experience in organic chemical synthesis at our fully integrated North American sitesUnique multifunctional excipients 
    SYLOID® multifunctional excipientsSILSOL® silica active ingredient delivery technologyHighly efficient chromatography resins 
    DAVISIL® silica, VYDAC® chromatography resins, and VYKING™ superparamagnetic silica